This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Queen's University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Challenges and opportunities for oncology drug repurposing informed by synthetic lethality.
NPJ systems biology and applications · 2025 · senior author
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes.
NPJ precision oncology · 2024 · senior author
Identifying tumorigenic non-coding mutations through altered cis-regulation.
STAR protocols · 2021
Latest funding
- $911,116
Translating synthetic lethality with common driver events into targeted therapies for high fatality cancers
CIHR · 2021 · Principal investigator
- $107,505
Dedicated Computational Infrastructure for Assembly and Analysis of Complex Genomes in Non-Model Organisms
NSERC · 2016 · Co-investigator
- $198,000
Molecular and computational tools for investigating genomic imprinting
NSERC · 2016 · Principal investigator
9 publications.
Challenges and opportunities for oncology drug repurposing informed by synthetic lethality.
Vermeulen M, Craig AW, Babak T
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes.
Truesdell P, Chang J, Coto Villa D, Dai M, Zhao Y, McIlwain R, Young S, Hiley S, Craig AW, Babak T
Identifying tumorigenic non-coding mutations through altered cis-regulation.
Cheng Z, Vermeulen M, Rollins-Green M, Babak T, DeVeale B
Author Correction: A one-step tRNA-CRISPR system for genome-wide genetic interaction mapping in mammalian cells.
Zhao Y, Tyrishkin K, Sjaarda C, Khanal P, Stafford J, Rauh M, Liu X, Babak T, Yang X
Lineage-specific selection and the evolution of virulence in the Candida clade.
Singh-Babak SD, Babak T, Fraser HB, Johnson AD
Cis-regulatory mutations with driver hallmarks in major cancers.
Cheng Z, Vermeulen M, Rollins-Green M, DeVeale B, Babak T
A one-step tRNA-CRISPR system for genome-wide genetic interaction mapping in mammalian cells.
Zhao Y, Tyrishkin K, Sjaarda C, Khanal P, Stafford J, Rauh M, Liu X, Babak T, Yang X
Erratum to: Dynamics of gene silencing during X inactivation using allele-specific RNA-seq.
Marks H, Kerstens HH, Barakat TS, Splinter E, Dirks RA, van Mierlo G, Joshi O, Wang SY, Babak T, Albers CA, Kalkan T, Smith A, Jouneau A, de Laat W, Gribnau J, Stunnenberg HG
Dynamics of gene silencing during X inactivation using allele-specific RNA-seq.
Marks H, Kerstens HH, Barakat TS, Splinter E, Dirks RA, van Mierlo G, Joshi O, Wang SY, Babak T, Albers CA, Kalkan T, Smith A, Jouneau A, de Laat W, Gribnau J, Stunnenberg HG
Translating synthetic lethality with common driver events into targeted therapies for high fatality cancers
Principal investigators: Craig, Andrew W; Babak, Tomas
Keywords: Cancer; Crispr/Cas9; Driver Mutations; Genome-Wide Screening; Patient-Derived Xenograft Models; Synthetic Lethality; Targeted Therapy; Tumour Xenograft Models
Dedicated Computational Infrastructure for Assembly and Analysis of Complex Genomes in Non-Model Organisms
Principal investigators: Colautti, Robert
Molecular and computational tools for investigating genomic imprinting
Principal investigators: Babak, Tomas
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Xiaolong Yang and Michael Rauh: 2 shared papers
- Xiaolong Yang and Tomas Babak: 2 shared papers
- Michael Rauh and Tomas Babak: 2 shared papers
- Cancer Biology and Genetics
- Pathology and Molecular Medicine
- Cell biology
Co-authors at Queen's University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.